NCT07450885

Brief Summary

The purpose of this study is to evaluate the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT) in individuals with asthma. This study aims to determine whether the BPAT is a valid and reliable tool for assessing breathing patterns in Turkish-speaking asthma patients. The research question being addressed is: "Is the Turkish version of the BPAT a valid and reliable tool for assessing breathing patterns in individuals with asthma?"

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

10 months

First QC Date

September 28, 2025

Last Update Submit

May 2, 2026

Conditions

Keywords

Brompton Breathing Pattern Assessment ToolTurkish VersionValidity StudyReliability Study

Outcome Measures

Primary Outcomes (1)

  • Construct Validity of the Turkish Version of the Brompton Breathing Pattern Assessment Tool (BPAT)

    The study aims to evaluate the construct validity of the Turkish version of the BPAT in assessing breathing patterns among Turkish-speaking asthma patients. Validity will be determined by calculating correlation coefficients (e.g., Spearman's or Pearson's r) between the total BPAT scores, objective physiological measures (spirometry results such as FEV1 and FVC), and the scores of established reference clinical tools (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), and Asthma Quality of Life Questionnaire (Mini-AQLQ).

    Baseline

Secondary Outcomes (3)

  • Test-Retest Reliability of the Turkish Version of BPAT

    7 to 14 days

  • Inter-Rater Reliability of the Turkish Version of BPAT

    Baseline

  • Comparison of BPAT Results with Other Asthma Assessment Tools

    Baseline

Study Arms (1)

Asthma Patients

Individuals aged 18-75, diagnosed with severe persistent asthma according to GINA criteria, who are native Turkish speakers.

Other: Brompton Breathing Pattern Assessment Tool (BPAT) - Turkish VersionOther: Validation Battery (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), Asthma Quality of Life Questionnaire (Mini AQLQ), Spirometry)

Interventions

A tool used to assess breathing patterns in asthma patients through clinical observation.

Asthma Patients

A set of validated questionnaires and objective tests used to compare with BPAT results for construct validity

Asthma Patients

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants for this study will be recruited from Health Sciences University, İstanbul Süreyyapaşa Chest Diseases and Chest Surgery Education and Research Hospital in Istanbul, Turkey. Participants will be selected based on the eligibility criteria outlined, including those diagnosed with severe persistent asthma as per the Global Initiative for Asthma (GINA) guidelines. Participants will be recruited from local clinics specializing in respiratory diseases and asthma management.

You may qualify if:

  • Aged between 18 and 75 years
  • Diagnosed with severe persistent asthma according to the Global Initiative for Asthma (GINA) criteria
  • Turkish ethnicity
  • Ability to read and write in Turkish
  • Willingness to participate in the study

You may not qualify if:

  • Having had a respiratory infection in the last 1 month
  • Use of oral corticosteroids in the last 4 weeks
  • Presence of malignancy, vasculitis, or pregnancy
  • Body Mass Index (BMI) \> 35 kg/m2
  • Diagnosis of COPD or other primary respiratory diseases (excluding asthma)
  • Any musculoskeletal, neurological, or cardiovascular condition that could interfere with breathing pattern assessment or impede potential respiratory physiotherapy applications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Süreyyapaşa Chest Diseases And Thoracic Surgery Training And Research Hospital

Istanbul, Istanbul, 34844, Turkey (Türkiye)

Location

Related Publications (1)

  • Todd S, Walsted ES, Grillo L, Livingston R, Menzies-Gow A, Hull JH. Novel assessment tool to detect breathing pattern disorder in patients with refractory asthma. Respirology. 2018 Mar;23(3):284-290. doi: 10.1111/resp.13173. Epub 2017 Sep 14.

    PMID: 28905471BACKGROUND

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Zuhal Kunduracılar, Prof.

    Istanbul Gelisim University

    PRINCIPAL INVESTIGATOR
  • Fatma M. Tepetam, Prof.

    Saglik Bilimleri Universitesi

    STUDY CHAIR
  • Şeyma Ozden, Dr.

    Saglik Bilimleri Universitesi

    STUDY CHAIR
  • Dilek Unsal, PT PhD(c)

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Nisanur Tutus, PT Phd (c)

    Saglik Bilimleri Universitesi

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

September 28, 2025

First Posted

March 5, 2026

Study Start

July 14, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared in order to protect patient confidentiality and comply with the local ethics committee regulations. However, completely anonymized data may be made available upon reasonable academic request to the Principal Investigator following the publication of the study results.

Locations